Investor Presentation

Here's a summary tailored to your preferences: **Financial Highlights:** Q1 FY26 revenue grew 20.4% YoY to **₹188.1 Cr**. EBITDA stood at **₹73.5 Cr** (39.1% margin), and PAT **₹38.3 Cr** (20.4% margin). The Hyderabad market saw double-digit growth.

Operational performance was strong, with **11 lakh** footfalls, **39.4 lakh** tests, and 93% B2C revenue. **Strategic Initiatives & Growth Drivers:** New hubs in Pune, Bengaluru, and West Bengal are operational, with the Nizamabad hub achieving quick break-even.

Three additional hubs are planned for Q2 FY26, and two more by H2 FY26, reinforcing the company's hub-and-spoke expansion strategy. **Business Developments:** Vijaya Diagnostic acquired P.H.

Diagnostics in Pune, integrating new centers under the Vijaya PH Brand.

Two hubs were also launched in Bengaluru, strategically entering this key market. **Market Position & Competitive Advantage:** As India's largest integrated B2C diagnostic chain, Vijaya dominates Telangana and AP.

Its integrated services, advanced equipment, and robust IT infrastructure provide a competitive edge, supporting high B2C concentration and strong margins. **Investor Implications:** Robust Q1 financials, coupled with effective strategic expansions and rapid break-even for new centers, signal positive growth potential.

Continued geographic diversification and a proven operational model suggest sustained revenue and margin stability.